In this sense, a recent study in Hispanic RA patients found a correlation between changes in serum PGRN levels and RA progression scores over time, although serum concentrations of PGRN did not predict the clinical response to TNF-α-antagonist therapy [190]. This evidence concerns the gene GRN and rheumatoid arthritis.